Arthritis Research UK Gout Treatment Trial - Phase 2

University of Nottingham517 enrolled

Overview

The purpose of this study is to determine in community-derived patients with gout the effectiveness, and cost effectiveness, of a nurse-led complex intervention that reflects recommended best practice (including patient information concerning gout, its prognosis and its non-pharmacological and drug options).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

517

Conditions

Gout

Interventions

Nurse interventionOTHER

Complex package of care involving patient information and advice concerning lifestyle modification and recommended drug therapy.

Standard careOTHER

Continuing standard General Practitioner led care.

Eligibility

Sex: ALLMin age: 21 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosis of gout * At least one acute attack of gout within previous 12 months Exclusion Criteria: \- Inability to give informed consent and known terminal or mental illness

Locations (1)

Academic Rheumatology, University of Nottingham

Nottingham, United Kingdom

Outcomes

Primary Outcomes

Reduction in serum uric acid levels

Time frame: 2 years

Secondary Outcomes

Reduction in number of self reported acute attacks during year 2

Time frame: 2 years

Improved Quality of Life scores at study end

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.